Main Article Content


Osteoarthritis (OA) is a degenerative joint disease characterized by the erosion of cartilage joints, hypertrophy of the marginal bone, subchondral sclerosis, and the morphological and biochemical changes of synovial membrane and joint capsule.This clinical syndrome is characterized by joint pain caused by degeneration of the joints. It is the most common joint disease to afflict the elderly and it occurs more often with age.1–3 Erosive osteoarthritis is a subset of OA in which there is a destruction of the joints as a result of inflammation.3,4 Changes mainly occur on the distal interphalangeal (DIP) joints, proximal interphalangeal (PIP) joints, carpometacarpal (CMC) joints, and very rarely occur on other joints of hand or of other body parts.3–5 The diagnosis is in accordance with the criteria of American College of Rheumatology (ACR) for OA and is supported by the existence of bone erosion on the radiological image. The management of this disease is merely for palliative purpose.

Article Details

How to Cite
Ongkowijaya, J. A., Setiyohadi, B., & Sumariyono, S. (2018). Erosive osteoarthritis. Indonesian Journal of Rheumatology, 2(1).


  1. Felson DT. Osteoarthritis. In: Imboden JB, Stone JH, Hellman DB, editors. Current rheumatology diagnosis and treatment. 2nd ed. New York: Lange; 2007. p. 339–44.
  2. Flores RH, Hochberg MC. Defi nition and classifi cation of osteoarthritis. In: Brandt K, Doherty M, Lohmander LS, editors. Osteoarthritis. 2nd ed. Oxford: Oxford University Press; 2003. p. 1–21.
  3. O’Reilly S, Doherty M. Clinical features of osteoarthritis and standard approaches to the diagnosis: signs, symptoms, and laboratory tests. In: Brandt K, Doherty M, Lohmander LS, editors. Osteoarthritis. 2nd ed. Oxford: Oxford University Press; 2003. p. 197–210.
  4. Stacy GS, Basu PA. Osteoarthritis, primary [Online]. 2009 Mar 17 [cited 2009 Apr 14]; Available from: URL:
  5. Indonesian Rheumatism Association. Guideline of diagnosis and management of osteoarthritis [Panduan diagnosis dan pengelolaan osteoartritis]. Jakarta: The Association; 2004.
  6. Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:377–88.
  7. Dieppe P. Osteoarthritis—clinical features. In: Klippel JH, Stone JH, Crofford LJ, White PH, editors. Primer on the rheumatic diseases. 13th ed. New York: Arthritis Foundation; 2008. p. 224–8.
  8. Erhlich GE. Erosive osteoarthritis: presentation, clinical pearls, and therapy. Curr Rheumatol Rep 2001;3:484–8.
  9. Daniel RS, Brown AN. Advanced erosive osteoarthritis [Online]. 2008 Nov 1 [cited 2009 Apr 14]; Available from: URL:
  10. Guido R, Patrizia M, Paolo S. Erosive osteoarthritis of hands: where we are and where we are going. Journal of Chinese Clinical Medicine 2008;3(3):121–2.
  11. Punzi L, Ramonda R, Sfriso P. Erosive osteoarthritis. Best Pract Res ClinRheumatol 2004;18(5):739–58.
  12. Riyazi N, Spee J, Huizinga TWJ, Schreuder GMT, de Vries RR, Dekker FW,et al. HLA class II is associated with distal interphalangeal osteoarthritis. Ann Rheum Dis 2003;62:227–30.
  13. Punzi L, Ramonda R, Oliviero F, Sfriso P, Mussap M, Plebani M, et al. Value of C-reactive protein in the assessment of erosive osteoarthritis of the hand. Ann Rheum Dis 2005;64:955–7.
  14. Bryant LR, Des Rosier KF, Carpenter MT. Hydroxychloroquine in the treatment of erosive osteoarthritis. J Rheumatol 1995;22(8):1598–605.
  15. Fioravanti A, Fabbroni M, Cerase A, Galeazzi M. Treatment of erosive osteoarthritis of the hands by intra-articular infl iximab injections: apilot study. Rheumatol Int [serial online] 2009 Jun [cited 2009 Apr 14]; 29(8):961–5. Available from: URL:

Most read articles by the same author(s)